Related Experiment Video
Updated: Jun 23, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients
M Vermeiden1, W W van den Broek, P G H Mulder
1Department of Psychiatry, Erasmus Medical Centre, Rotterdam, The Netherlands.
Abstract:
The present study investigated the influence of gender and menopausal status on treatment response in depressed inpatients, treated with either imipramine or fluvoxamine. The patients were divided into three groups: men, premenopausal women and postmenopausal women. A multivariate analysis was performed using the difference in Hamilton score (pretreatment - post-treatment) for imipramine and fluvoxamine as dependent variable. The following independent variables were used: the baseline Hamilton score, the antidepressant used, the gender-group and the interaction between the type of antidepressant and gender. In total, 138 patients with a DSM IV diagnosis of depressive disorder were analysed. Men responded more favorably to imipramine (B = 7.12, P = 0.005). Premenopausal women had a better response rate to fluvoxamine than men (B = -8.66, P = 0.027). In depressed inpatients, men respond more favorably to imipramine than to fluvoxamine. Premenopausal women respond more frequently to fluvoxamine than men.
Related Concept Videos
Menopause
Antidepressant Drugs: MAOIs and Other Agents
Panic Disorder
Antidepressant Drugs: Overview
The Placebo Effect
Pharmacodynamics in Geriatric Patients: Effects of Age

